Radiopharmacy of Indianapolis (ROI) Introduces the RadioGenix System to their Tc-99m Profile
ROI is proud to lead the way once again in implementing new technologies that will help our customers and continue our innovative solutions mindset.
ROI is Excited to Begin Offering NETSPOT (Ga-68 Dotatate)
NETSPOT, after radiolabeling with Ga-68, is a radioactive diagnostic agent indicated for use with PET for localization of somatostatin receptor positive neuroendocrine tumors in adult and pediatric patients.
Proud Sponsor of the 2017 CCSNMMI Indiana Road Show
Radiopharmacy of Indianapolis is a proud sponsor of the 2017 Central Chapter Society of Nuclear Medicine and Molecular Imaging Indiana Road Show
Another Drug Shortage. Another Price Hike?
Nuclear Medicine is going through a change in the marketplace. To address some of these concerns we want to provide you with a perspective from Leah Gannon from Vizient. We have received inquiries about the possibility of a Technetium 99m (Tc99m) shortage and international and national mandates aimed at increasing national security by producing only non-HEU based Mo-99.